Vertex Pharmaceuticals (NQ: VRTX )
471.56
+4.28
(+0.92%)
Streaming Delayed Price
Updated: 2:23 PM EDT, Jun 20, 2024
Add to My Watchlist
Press Releases about Vertex Pharmaceuticals
![](https://mms.businesswire.com/media/20240613723433/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240606593406/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240522554872/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240513941236/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240509132613_will-the-biotech-sector-shift-from-lagger-to-leade.jpg)
![](https://mms.businesswire.com/media/20240506449207/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240418505520/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240410250636/en/1405071/5/AIS-Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240409792882/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240401185946_biotech-sector-nears-breakout-will-it-outperform-i.jpg)
![](https://mms.businesswire.com/media/20240401112879/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240321788878/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240319192215_geron-stock-doubles-after-imetelstat-receives-fda.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240226142303_bluebird-bio-how-to-play-leaps-options-for-growth.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240225182115_is-crispr-therapeutics-the-nvidia-of-gene-editing.jpg)
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence
![](https://mms.businesswire.com/media/20240220983064/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex to Participate in Upcoming Investor Conferences
February 20, 2024
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg)
![](https://mms.businesswire.com/media/20240205102953/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240205690690/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex Reports Fourth Quarter and Full Year 2023 Financial Results
February 05, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240205149775/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240129843577/en/2013275/5/Chart_2.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240122114449_2-gene-editing-stocks-to-keep-on-your-2024-watchli.jpg)
![](https://mms.businesswire.com/media/20240117256864/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240116502203/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20240109040535/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240108072132_2-low-priced-gene-therapy-stocks-to-speculate-on.jpg)
![](https://mms.businesswire.com/media/20240107188174/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240104092418_will-the-biotech-sector-sustain-its-momentum-in-20.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.